Indomethacin farnesil
From Wikipedia, the free encyclopedia
Indomethacin farnesil is a novel antiinflammatory prodrug of indomethacin designed to reduce the occurrence of side-effects by esterification of the carboxyl group on indomethacin with farnesol. Indomethacin farnesil is marketed as trade names Infree and Dialon. CAS: 85801-02-1
[edit] External links
| Non-steroidal anti-inflammatory drugs (primarily M01A and M02A, also N02BA) edit | ||
|---|---|---|
|
Salicylates: Aspirin (Acetylsalicylic Acid), Diflunisal, Ethenzamide -- Arylalkanoic acids: Diclofenac, Indometacin, Sulindac 2-Arylpropionic acids (profens): Carprofen, Flurbiprofen, Ibuprofen, Ketoprofen, Ketorolac, Loxoprofen, Naproxen, Tiaprofenic acid, N-Arylanthranilic acids (fenamic acids): Mefenamic acid -- Pyrazolidine derivatives: Phenylbutazone Oxicams: Meloxicam, Piroxicam -- Coxibs: Celecoxib, Etoricoxib, Parecoxib, Rofecoxib, Valdecoxib -- Sulphonanilides: Nimesulide Topically used products: Diclofenac, Flurbiprofen, Ibuprofen, Indometacin, Ketoprofen, Naproxen, Piroxicam |
||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
